Kadiané-Oussou, N., & al, et. (2024). Twelve-month outcome of pretreated immunodeficiency virus 1-infected patients receiving triple antiretroviral therapy including dolutegravir in Bouaké (Côte D’Ivoire) from 2020 to 2021. Revue Malienne d’Infectiologie Et De Microbiologie, 18(2), 50–56. https://doi.org/10.53597/remim.v18i2.2734